JPS6054959B2 - carbostyril derivatives - Google Patents

carbostyril derivatives

Info

Publication number
JPS6054959B2
JPS6054959B2 JP8781777A JP8781777A JPS6054959B2 JP S6054959 B2 JPS6054959 B2 JP S6054959B2 JP 8781777 A JP8781777 A JP 8781777A JP 8781777 A JP8781777 A JP 8781777A JP S6054959 B2 JPS6054959 B2 JP S6054959B2
Authority
JP
Japan
Prior art keywords
acid
compound
general formula
reaction
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP8781777A
Other languages
Japanese (ja)
Other versions
JPS5422375A (en
Inventor
剛文 清水
量之 中川
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Priority to JP8781777A priority Critical patent/JPS6054959B2/en
Publication of JPS5422375A publication Critical patent/JPS5422375A/en
Publication of JPS6054959B2 publication Critical patent/JPS6054959B2/en
Expired legal-status Critical Current

Links

Description

【発明の詳細な説明】 本発は新規なりルボスチリル誘導体に関する。[Detailed description of the invention] The present invention relates to novel rubostyril derivatives.

本発明の化合物は、新規化合物であつて、一般式〔式中
Rは低級アルキル基を、 OHOHC2H5 1又は 1: を、カル ー0CH2CHCH2−一℃H−CH− ボスチリル骨格の3、4位の結合は一重結合又は二重結
合を夫々示す。
The compound of the present invention is a novel compound, which has the general formula [wherein R is a lower alkyl group, OHOHC2H5 1 or 1:], and the bonds at the 3rd and 4th positions of the bostyryl skeleton are Indicates a single bond or a double bond, respectively.

〕で表わされるカルボスチリル誘導体及びその酸付加塩
である。本発明の化合物は優れたβ−アドレナリン作動
神経刺激作用及び胃酸分泌抑制作用を有し、抗喘息薬、
抗潰瘍薬等として有用である。上記一般式〔1〕に於て
、Rで示される低級アルキル基としては炭素数1〜4の
直鎖もしくは分岐状のアルキル基を挙げることができ、
具体的にはメチル、エチル、プロピル、イソプロピル、
ブチル、tert−ブチル基等を例示できる。
] and its acid addition salts. The compound of the present invention has excellent β-adrenergic nerve stimulating action and gastric acid secretion suppressing action, and is an anti-asthmatic drug.
It is useful as an anti-ulcer drug. In the above general formula [1], the lower alkyl group represented by R may include a straight chain or branched alkyl group having 1 to 4 carbon atoms,
Specifically, methyl, ethyl, propyl, isopropyl,
Examples include butyl and tert-butyl groups.

本発明化合物のうち代表的なものを以下に掲げる。05
−(2−ヒドロキシー3−Tert−ブチルアミノプロ
ポキシ)−8−(β−D−グルクロン酸−1−イル)−
3,4−ジヒドロカルボスチリル05−(2−ヒドロキ
シー3−イソプロピルアミノプロポキシ)−8−(β−
D−グルクロン酸−1−イル)カルボスチリル05−(
2−ヒドロキシー3−エチルアミノプロポキシ)−8−
(β−D−グルクロン酸−1ーイル)−3,4−ジヒド
ロカルボスチリル05−(1−ヒドロキシー2−イソプ
ロピルアミノブチル)−8−(β−D−グルクロン酸一
1−イル)カルボスチリル05−(1−ヒドロキシー2
−Tert−ブチルアミノブチル)−8−(β−D−グ
ルクロン酸一1−イル)−3,4−ジヒドロカルボスチ
リル本発明の化合物は種々の方法により合成されるが、
その好ましい一例を挙げれば下式に示すようにして製造
される。
Representative compounds of the present invention are listed below. 05
-(2-Hydroxy-3-Tert-butylaminopropoxy)-8-(β-D-glucuronic acid-1-yl)-
3,4-dihydrocarbostyryl 05-(2-hydroxy-3-isopropylaminopropoxy)-8-(β-
D-glucuronic acid-1-yl) carbostyril 05-(
2-Hydroxy-3-ethylaminopropoxy)-8-
(β-D-glucuronic acid-1-yl)-3,4-dihydrocarbostyryl 05-(1-hydroxy-2-isopropylaminobutyl)-8-(β-D-glucuronic acid-1-yl)carbostyryl 05- (1-hydroxy-2
The compound of the present invention can be synthesized by various methods, including
A preferable example thereof is produced as shown in the following formula.

塩基性化合物 「゛゜″゛且4゛] 加水分解 5冨筺] 〔上式に於てR1は低級アルカノイル基、R2は低級ア
ルキル基、Xはハロゲン原子を示す。
Basic Compound "゛゜"゛[4゛] Hydrolyzed 5-Tomi] [In the above formula, R1 is a lower alkanoyl group, R2 is a lower alkyl group, and X is a halogen atom.

R,A及び3,4位の結合は前記に同じ。〕即ち塩基性
化合物の存在下一般式〔旧で表わされる公知の8−ヒド
ロキシカルボスチリル誘導体と一般式〔■〕で表わされ
る公知のグルクロン酸誘導体とを反応させて一般式〔■
〕で表わされ”る新規なりルボスチリル誘導体を得、次
いで一般式〔■〕の化合物を単離精製するか或いは単離
精製することなく、一般式〔■〕の化合物からR1及び
R2で示される保護基を除去することにより本発明化合
物が製造される。
The bonds at the R, A and 3rd and 4th positions are the same as above. ] That is, in the presence of a basic compound, a known 8-hydroxycarbostyryl derivative represented by the general formula [formula] and a known glucuronic acid derivative represented by the general formula [■] are reacted to form the general formula [■].
], and then isolate and purify the compound of the general formula [■], or without isolating and purifying it, from the compound of the general formula [■] represented by R1 and R2. The compound of the present invention is produced by removing the protecting group.

一般式〔■)の化合物と一般式〔■〕の化合物との反応
は慣用の不活溶媒中にて行なうのがよい。
The reaction between the compound of general formula [■] and the compound of general formula [■] is preferably carried out in a conventional inert solvent.

斯かる溶媒としては水、メタノール、エタノール、プロ
パノール等の低級アルコール類、ジオキサン、テトラヒ
ドロフラン等のエーテル類、アセトン、メチルエチルケ
トン等のケトン類、ベンゼン、トルエン等の芳香族炭化
水素類、酢酸エチル、酢酸メチル等のエステル類、ジメ
チルスルホキシド、ジメチルホルムアミドやこれらの混
合溶媒を例示できる。一般式〔旧の化合物と一般式〔■
〕の化合物との使用割合は特に限定されず広い範囲から
適宜選択されるが、通常前者に対して後者を等モル〜5
倍モル、好ましくは等モル〜2倍モル量用いるのがよい
。該反応は塩基性化合物の存在下に行なわれる。使用さ
れる塩基性化合物としてはナトリウム、カリウム等のア
ルカリ金属、ナトリウムメチラート、ナトリウムエチラ
ート、カリウムエチラート等のアルカリ金属アルコラー
ト、水酸化ナトリウム、水酸化カリウム、水酸化カリシ
ウム等のアルカリ金属もしくはアルカリ土類金属の水酸
化物等を例示てきる。塩基性化合物の使用量としては特
に限定されず広い範囲から適宜選択して使用されるが、
一般式〔■〕の化合物に対して通常等モル〜5倍モル、
好ましくは等モル〜2倍モル量用いるのがよい。反応温
度は通常0〜50゜C1好ましくはO〜30℃とするの
がよく、通常1時間〜3日間で反応は終了する。斯くし
て得られる一般式〔■〕の化合物はそのままで或いは単
離精製された後、一般式〔■〕の化合物からR1及びR
2で示される保護基を除去すべく処理される。保護基の
除去方法としては例えば通常の酸又は塩基性化合物を触
媒に用いる加水分解反応による方法を挙げることができ
る。斯かる酸又は塩基性化合物としてはナトリウムメチ
ラート、ナトリウムエチラート、カリウムエチラート等
のアルカリ金属アルコラート、水酸化カリウム、水酸化
ナトリウム、水酸化カルシウム等のアルカリ金属もしく
はアルカリ土類金属の水酸化物、炭酸ナトリウム、炭酸
カリウム、炭酸水素カリウム等のアルカリ金属炭酸化物
、塩酸、硫酸、リン酸等の無機酸、p−トルエンスルホ
ン酸、酢酸等の有機酸、酸性もしくは塩基性のイオン交
換樹脂等を例示できる。該反応は水、メタノール、エタ
ノール、プロパノール等の低級アルコール類、ジオキサ
ン、テトラヒドロフラン等の溶媒中にて行なうのがよい
。反応温度は通常0〜50℃、好ましくは0〜30℃と
するのがよく、通常3紛〜2日間で反応は終了する。斯
くして得られる一般式〔1〕の化合物は反応終了後常法
に従つて反応混合物から単離される。
Such solvents include water, lower alcohols such as methanol, ethanol and propanol, ethers such as dioxane and tetrahydrofuran, ketones such as acetone and methyl ethyl ketone, aromatic hydrocarbons such as benzene and toluene, ethyl acetate and methyl acetate. Examples include esters such as, dimethyl sulfoxide, dimethyl formamide, and mixed solvents thereof. General formula [Old compound and general formula]
] The ratio of the compound to be used is not particularly limited and is appropriately selected from a wide range, but usually the latter is used in an equimolar to 5 molar ratio to the former.
It is preferable to use twice the molar amount, preferably equimolar to twice the molar amount. The reaction is carried out in the presence of a basic compound. The basic compounds used include alkali metals such as sodium and potassium, alkali metal alcoholates such as sodium methylate, sodium ethylate, and potassium ethylate, and alkali metals or alkalis such as sodium hydroxide, potassium hydroxide, and potassium hydroxide. Examples include earth metal hydroxides. The amount of the basic compound to be used is not particularly limited and may be appropriately selected from a wide range.
Usually equimolar to 5 times the molar amount of the compound of general formula [■],
It is preferable to use equimolar to twice the molar amount. The reaction temperature is usually 0 to 50°C, preferably 0 to 30°C, and the reaction is usually completed in 1 hour to 3 days. The compound of the general formula [■] obtained in this way is used as it is or after being isolated and purified, R1 and R are obtained from the compound of the general formula [■].
2 is treated to remove the protecting group shown in 2. As a method for removing the protecting group, for example, a method using a hydrolysis reaction using a conventional acid or basic compound as a catalyst can be mentioned. Such acid or basic compounds include alkali metal alcoholates such as sodium methylate, sodium ethylate, and potassium ethylate, and alkali metal or alkaline earth metal hydroxides such as potassium hydroxide, sodium hydroxide, and calcium hydroxide. , alkali metal carbonates such as sodium carbonate, potassium carbonate, and potassium hydrogen carbonate, inorganic acids such as hydrochloric acid, sulfuric acid, and phosphoric acid, organic acids such as p-toluenesulfonic acid and acetic acid, acidic or basic ion exchange resins, etc. I can give an example. The reaction is preferably carried out in a solvent such as water, a lower alcohol such as methanol, ethanol or propanol, dioxane or tetrahydrofuran. The reaction temperature is usually 0 to 50°C, preferably 0 to 30°C, and the reaction is usually completed in 3 to 2 days. After completion of the reaction, the compound of general formula [1] thus obtained is isolated from the reaction mixture according to a conventional method.

例えば溶媒による抽出法、再結晶、カラムクロマトグラ
フィー等通常の方法により単離、精製することができる
。一般式〔1〕の化合物は医薬的に許容される酸と容易
に酸付加塩を形成させることができる。
For example, it can be isolated and purified by conventional methods such as extraction with a solvent, recrystallization, and column chromatography. The compound of general formula [1] can easily form an acid addition salt with a pharmaceutically acceptable acid.

斯かる酸としては塩酸、臭化水素酸、硫酸、リン酸等の
無機酸、シユウ酸、マレイン酸、フマール酸、コハク酸
、酒石酸、p−トルエンスルホン酸、酢酸等の有機酸等
を挙げることができる。更に本発明は光学異性体も包含
する。以下に実施例を掲けて本発明をよソー層明らかに
する。
Examples of such acids include inorganic acids such as hydrochloric acid, hydrobromic acid, sulfuric acid, and phosphoric acid, and organic acids such as oxalic acid, maleic acid, fumaric acid, succinic acid, tartaric acid, p-toluenesulfonic acid, and acetic acid. Can be done. Furthermore, the present invention also includes optical isomers. Examples are given below to clearly explain the present invention.

実施例1水酸化カリウム5.3yをメタノール300m
1に溶解する。
Example 1 5.3y of potassium hydroxide was added to 300ml of methanol.
Dissolve in 1.

この溶液に5−(1−ヒドロキシー2−イソプロピルア
ミノブチル)−8−ヒドロキシカルボスチリル塩酸塩1
3yを加え溶解し濃縮乾固する。塩化カルシウム管及び
滴下ロードを付けた三頚フラスコにメチル(トリー0−
アセチルーα一D−グルコピラノシルプロマイド)ウロ
ネート19yをアセトン100m1に溶解し、水冷攪拌
下上記で調製したカリウム塩のメタノール溶液を滴下す
る。滴下に従つて反応液は褐色から黒褐色に変化する。
3日間室温で攪拌反応させたのち反応液を低温で濃縮す
る。
Add 1 % of 5-(1-hydroxy-2-isopropylaminobutyl)-8-hydroxycarbostyril hydrochloride to this solution.
Add 3y, dissolve and concentrate to dryness. Add methyl (Try 0-
Acetyl-α-D-glucopyranosylbromide) uronate 19y is dissolved in 100 ml of acetone, and the methanol solution of the potassium salt prepared above is added dropwise while stirring under water cooling. The reaction solution changes from brown to blackish brown as it is added dropwise.
After stirring the reaction at room temperature for 3 days, the reaction solution is concentrated at a low temperature.

この残渣を少量の水に溶解しアンパーライトXAD−2
−(280m1)に吸着し1.5倍量の水でカラムを洗
浄する。次いで5。0%エタノール600r!Llで溶
出し濃縮する。
Dissolve this residue in a small amount of water and prepare Amperlite XAD-2.
- (280ml) and wash the column with 1.5 times the amount of water. Next, 600 r of 5.0% ethanol! Elute with Ll and concentrate.

残渣を再び少量の水に溶解後セフアーデツクスLH−2
0を用いて分離する。この分面を濃縮し残渣にCH3O
Nαーメタノール溶液(0.5y−50m1)50m1
を加えて室温て約5時間放置し加水分解する。加水分解
後酢酸で中和し再度セフアーデツクスLH−20を用い
て分離する。この分画をQAE−セフアーデツクスA−
25(CH3COO一型)を用いて精製(溶媒:水)し
て、白色無定形晶の5−(1−ヒドロキシー2−イソプ
ロピルアミノブチル)−8−(β一D−グルクロン酸−
1−イル)カルボスチリル31鉢和物7.6yを得る。
融点204℃(分解) 実施例2 水酸化カリウム1.3qをメタノール40mtに溶解し
た液に5−(2−ヒドロキシー3−Tert−ブチjル
アミノプロポキシ)−8−ヒドロキシー3,4ージヒド
ロカルボスチリル塩酸塩3,4yを加えて溶解する。
After dissolving the residue in a small amount of water again, Sephadex LH-2
Separate using 0. This fraction is concentrated and the residue is CH3O.
Nα-methanol solution (0.5y-50ml) 50ml
Add and leave at room temperature for about 5 hours to hydrolyze. After hydrolysis, it is neutralized with acetic acid and separated again using Sephadex LH-20. This fraction was converted into QAE-Secardex A-
25 (CH3COO type 1) (solvent: water) to give white amorphous crystals of 5-(1-hydroxy-2-isopropylaminobutyl)-8-(β-D-glucuronic acid-
1-yl) Carbostyril 31 potacylate 7.6y is obtained.
Melting point: 204°C (decomposed) Example 2 5-(2-hydroxy-3-Tert-butylaminopropoxy)-8-hydroxy-3,4-dihydrocarbostyryl was added to a solution of 1.3 q of potassium hydroxide dissolved in 40 mt of methanol. Add and dissolve hydrochloride 3,4y.

減圧濃縮後残渣をメタノール30m1に溶解しp液を予
めアセトン40m1に溶解したメチル(トリー0−アセ
チルーα−D−グルコピラノシLルブ七マイド)ウロネ
ート4.2yに水冷攪拌下滴下する。この反応液を室温
で3日間攪拌したのち反応液を濃縮後セフアーデツクス
LLI−20に吸着し30%エタノールで溶出する。溶
出液を濃縮したのちCH3ONα−メタノール(イ).
5y−50mL)を加)え少し加温したのち室温に一夜
放置する。この反応液を再度濃縮したのち少量の水に溶
解しセフアーデツクスLH−20に吸着し30%工ター
ルで溶出する。更にQAE−セフアーデツクスA−25
(CH3COO一型)を用いて精製後セフアーデツクス
LH−20に吸着し30%エタノールで溶出する。この
溶出液よりメタノ−ルーエチルエーテルを用いて結晶化
させることにより淡黄色無定形晶の5一(2−ヒドロキ
シー3−Tert−ブチルアミノプロポキシ)−8−(
β−D−グルクロン酸−1−イル)−3,4−ジヒドロ
カルボスチリル1.63yを得る。融点21rc(分解
After concentration under reduced pressure, the residue was dissolved in 30 ml of methanol, and the p solution was added dropwise to 4.2 y of methyl (tri-0-acetyl-α-D-glucopyranosyl L-rubu7amide) uronate, which had been previously dissolved in 40 ml of acetone, under water cooling and stirring. After stirring the reaction solution at room temperature for 3 days, the reaction solution was concentrated, adsorbed onto Sephadex LLI-20, and eluted with 30% ethanol. After concentrating the eluate, CH3ONα-methanol (a).
5y-50 mL), warmed slightly, and then left at room temperature overnight. After concentrating the reaction solution again, it was dissolved in a small amount of water, adsorbed on Sephadex LH-20, and eluted with 30% tar. Furthermore, QAE-Security Index A-25
After purification using (CH3COO type 1), it was adsorbed on Sephadex LH-20 and eluted with 30% ethanol. This eluate was crystallized using methanol-ethyl ether to give pale yellow amorphous crystals of 5-(2-hydroxy-3-Tert-butylaminopropoxy)-8-(
1.63y of β-D-glucuronic acid-1-yl)-3,4-dihydrocarbostyryl is obtained. Melting point 21rc (decomposition)

Claims (1)

【特許請求の範囲】 1 一般式 ▲数式、化学式、表等があります▼ 〔式中はRは低級アルキル基を、Aは ▲数式、化学式、表等があります▼又は▲数式、化学式
、表等があります▼を、カルボスチリル骨格の3、4位
の結合は一重結合又は二重結合を夫々示す。 〕で示わされるカルボスチリル誘導体及びその酸付加塩
[Claims] 1 General formula ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ [In the formula, R is a lower alkyl group, A is ▲ There are ▲ mathematical formulas, chemical formulas, tables, etc. ▼ or ▲ Numerical formulas, chemical formulas, tables, etc. There is ▼, and the bonds at the 3rd and 4th positions of the carbostyril skeleton represent a single bond or a double bond, respectively. ] Carbostyryl derivatives and acid addition salts thereof.
JP8781777A 1977-07-20 1977-07-20 carbostyril derivatives Expired JPS6054959B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP8781777A JPS6054959B2 (en) 1977-07-20 1977-07-20 carbostyril derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8781777A JPS6054959B2 (en) 1977-07-20 1977-07-20 carbostyril derivatives

Publications (2)

Publication Number Publication Date
JPS5422375A JPS5422375A (en) 1979-02-20
JPS6054959B2 true JPS6054959B2 (en) 1985-12-03

Family

ID=13925512

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8781777A Expired JPS6054959B2 (en) 1977-07-20 1977-07-20 carbostyril derivatives

Country Status (1)

Country Link
JP (1) JPS6054959B2 (en)

Also Published As

Publication number Publication date
JPS5422375A (en) 1979-02-20

Similar Documents

Publication Publication Date Title
EP0233760B1 (en) Sulfenamide derivatives and their production
JPS6312063B2 (en)
JPS61129145A (en) Manufacture of hydroquinone derivative
JPS6054959B2 (en) carbostyril derivatives
US3793314A (en) Cinnamic acid esters of 7-nitro-8-hydroxy-quinoline
EP0435235B1 (en) Isoquinoline derivatives and salts thereof as protease inhibitors.
HU177512B (en) Process for preparing daunorubicin derivatives
GB2067990A (en) Cinnamyl moranoline derivatives
GB2106516A (en) Anthranilic acid esters
JPS60185766A (en) Novel azabicyclo compound and manufacture
JPH0745498B2 (en) t-butyl ergoline derivative
US4123545A (en) N-Propyl-3(β-hydroxyethyl)-3-(meta-hydroxyphenyl)-pyrrolidine
JPS6039264B2 (en) Method for producing 3-amino-2-hydroxy-4-p-hydroxyphenylbutanoylleucine and its derivatives
KR800000736B1 (en) Process for preparing 4-oxo-1,2,3,4-tetra hydropyrido(2,3-d)pyrimidin derivatives
JP3942674B2 (en) Method for producing esculetin derivative in which 7-position hydroxyl group is selectively protected
KR820001081B1 (en) Process for preparing moranoline derivatives
KR840000152B1 (en) Process for preparing 2-azaerythrinan derivatives
KR810001958B1 (en) Process for preparing moranolin derivatives
KR790001648B1 (en) Process for the preparation of trimethoxy benzyl piperazino ethanol deriyatives
KR820001122B1 (en) Process for preparing n-alkenyl moranoline derivatives
JPS6051472B2 (en) 3,4-dihydrocarbostyryl derivative
IE42462B1 (en) 1-methyl-2-nitro-imidazole-5-methanol derivatives
GB1561679A (en) 3,3 - diphenylpropylamine derivatives
JPS6043067B2 (en) 2-Alkoxyindolizine derivatives and their production method
JPS5936619B2 (en) Method for producing carbostyril derivatives